| Previous close | 9.00 |
| Open | 4.00 |
| Bid | 16.10 |
| Ask | 18.95 |
| Strike | 1.00 |
| Expiry date | 2025-01-17 |
| Day's range | 4.00 - 9.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
ZacksModerna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Moderna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1 to the FDA for the upcoming vaccination season.
ZacksInvestors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Simply Wall St.Novavax, Inc. (NASDAQ:NVAX) has caught the attention of institutional investors who hold a sizeable 49% stake
Key Insights Institutions' substantial holdings in Novavax implies that they have significant influence over the...
© 2024 Yahoo. All rights reserved.